Open AccessPhase 1b Dose‐finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B‐cell Lymphoma
Author(s) -
Petrillo Alessandra,
Ip Andrew,
Della Pia Alexandra,
Gill Sarvainder,
Zenreich Joshua,
Gutierrez Martin,
McNeill Ann,
Feldman Tatyana,
Leslie Lori A.,
Goy Andre
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000719
Subject(s) - ibrutinib , rituximab , medicine , venetoclax , oncology , diffuse large b cell lymphoma , lymphoma , vincristine , cancer research , salvage therapy , chemoimmunotherapy , cyclophosphamide , chemotherapy , leukemia , chronic lymphocytic leukemia